The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Role of CCL5 (RANTES) in Viral Lung Disease
Abstract
CCL5/RANTES is a key proinflammatory chemokine produced by virus-infected epithelial cells and present in respiratory secretions of asthmatics. To examine the role of CCL5 in viral lung disease, we measured its production during primary respiratory syncytial virus (RSV) infection and during secondary infection after sensitizing vaccination that induces Th2-mediated eosinophilia. A first peak of CCL5 mRNA and protein production was seen at 18 to 24 h of RSV infection, before significant lymphocyte recruitment occurred. Treatment in vivo with Met-RANTES (a competitive chemokine receptor blocker) throughout primary infection decreased CD4+and CD8+cell recruitment and increased viral replication. In RSV-infected, sensitized mice with eosinophilic disease, CCL5 production was further augmented; Met-RANTES treatment again reduced inflammatory cell recruitment and local cytokine production. A second wave of CCL5 production occurred on day 7, attributable to newly recruited T cells. Paradoxically, mice treated with Met-RANTES during primary infection demonstrated increased cellular infiltration during reinfection. We therefore show that RSV induces CCL5 production in the lung and this causes the recruitment of RSV-specific cells, including those making additional CCL5. If this action is blocked with Met-RANTES, inflammation decreases and viral clearance is delayed. However, the exact effects of chemokine modulation depend critically on time of administration, a factor that may potentially complicate the use of chemokine blockers in inflammatory diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to playing a distinct role in the early clinical course and persistence of SARS in infected patients, differential chemokine expression is observed in viral lung disease caused by respiratory syncytial virus (RSV) (36).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [36]
Citations
Cites
Community study of role of viral infections in exacerbations of asthma in 9–11 year old children
Johnston, S. L., Pattemore, P. K., Sanderson, G., Smith, S., Lampe, F., Josephs, L., Symington, P., Toole, S. O., Myint, S. H., Tyrrell, D. A. J., et al. (1995) · BMJ · doi:10.1136/bmj.310.6989.1225 · Cited by 1,991
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K. B., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,378
Severe Respiratory Syncytial Virus Bronchiolitis in Infancy and Asthma and Allergy at Age 13
Sigurs, N., Gustafsson, P., Bjarnason, R. G., Lundberg, F., Schmidt, S., Sigurbergsson, F., & Kjellman, B. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-730oc · Cited by 954
Rongvaux, A., Shea, R. J., Mulks, M. H., Gigot, D., Urbain, J., Léo, O., & Andris, F. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11 · Cited by 551
Lloyd, C. M., Minto, A. W., Dorf, M. E., Proudfoot, A. E. I., Wells, T. N. C., Salant, D. J., & Gutierrez-Ramos, J.-C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1371 · Cited by 496
Self-citationProudfoot, A. E. I., Power, C. A., Hoogewerf, A. J., Montjovent, M., Borlat, F., Offord, R. E., & Wells, T. N. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2599 · Cited by 418
Self-citationCCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells
Aliberti, J., Sousa, C. R. E., Schito, M. L., Hieny, S. E., Wells, T. N. C., Hu, B., & Sher, A. (2000) · Nature Immunology · doi:10.1038/76957 · Cited by 349
Self-citationSchwarze, J., Hamelmann, E. H., Bradley, K., Takeda, K., & Gelfand, E. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119516 · Cited by 328
Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation
Randolph, D. A., Stephens, R., Carruthers, C. J. L., & Chaplin, D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7631 · Cited by 301
Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection
Openshaw, P., & Tregoning, J. S. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.541-555.2005 · Cited by 299
Self-citation
Cited by
Sorted by citations
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology
Tregoning, J. S., & Schwarze, J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00032-09 · Cited by 768
Self-citationPlatelets and Infection – An Emerging Role of Platelets in Viral Infection
Assinger, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00649 · Cited by 389
“CCL5 is further involved in viral lung diseases (87).”
BackgroundTargeting CCL5 in inflammation
Marques, R. E., Guabiraba, R., Russo, R. C., & Teixeira, M. M. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.837886 · Cited by 384
“However, chemokine blockade during the first phase showed opposite effects, which makes it difficult to anticipate what would be the effects of targeting this pathway in clinical studies [63].”
BackgroundPribul, P. K., Harker, J. A., Wang, B. L., Wang, H., Tregoning, J. S., Schwarze, J., & Openshaw, P. (2008) · Journal of Virology · doi:10.1128/jvi.02541-07 · Cited by 201
“tion of Met-RANTES (a competitive inhibitor) reduces both the CD4 and CD8 responses to RSV (4).”
BackgroundSelf-citationMunir, S., Nouën, C. L., Luongo, C., Buchholz, U. J., Collins, P. L., & Bukreyev, A. A. (2008) · Journal of Virology · doi:10.1128/jvi.00630-08 · Cited by 122
“In the mouse model, RANTES/CCL5 has also been shown to contribute to exacerbation of allergic airway inflammation by RSV (33) and plays a central role in lung inflammation during RSV infection (17).”
BackgroundMethodTregoning, J. S., Yamaguchi, Y., Harker, J. A., Wang, B. L., & Openshaw, P. (2008) · Journal of Virology · doi:10.1128/jvi.02313-07 · Cited by 112
“IL-2, IL-4, IL-13, and CCL5 levels all decreased in proportion to the decrease in inflammation (Table 2).”
InfluentialSelf-citationLindell, D. M., Lane, T. E., & Lukacs, N. W. (2008) · European Journal of Immunology · doi:10.1002/eji.200838155 · Cited by 103
“In contrast, using a combination of reagents to block CCL5 or CCR1−/− mice numerous studies have shown that this highly expressed chemokine/receptor pathway corresponds to a detrimental pathologic consequence [13,37,38,42,43].”
Host immunity during RSV pathogenesis
Bueno, S. M., González, P. A., Pacheco, R., Leiva, E., Cautivo, K. M., Tobar, H. E., Mora, J. E., Prado, C. E., Zuniga-Hertz, J. P., Jiménez, J., et al. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.03.012 · Cited by 103
“Similarly, treatment of mice with MetRANTES (a competitor for RANTES receptor) reduced the recruitment of inflammatory cells to the lung [32].”
BackgroundContribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection
Böhmwald, K., Gálvez, N. M. S., Canedo-Marroquín, G., Pizarro-Ortega, M. S., Andrade, C. A., Gómez‐Santander, F., & Kalergis, A. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00452 · Cited by 99
“Along these lines, blockage of CCL5 reduced both weight loss and eosinophilia, suggesting that this cytokine plays an essential role during lung inflammation (157).”
BackgroundInfluentialThe Host Response and Molecular Pathogenesis Associated with Respiratory Syncytial Virus Infection
Oshansky, C. M., Zhang, W., Moore, E., & Tripp, R. A. (2009) · Future Microbiology · doi:10.2217/fmb.09.1 · Cited by 93
“Consistent with this view, in vivo chemokine blockade reduces RSV-associated lung pathology in mice treated with anti-RANTES antibodies [130], and treatment of RSV-infected mice with a competitor of the RANTES receptor (Met-RANTES) reduces recruitment of inflammatory cells to the lung [225].”
BackgroundHung, C.-Y., González, Á., Wüthrich, M., Klein, B. S., & Cole, G. T. (2011) · Infection and Immunity · doi:10.1128/iai.05726-11 · Cited by 87
“Release of this chemokine from host cells is induced by the presence of IFNand TNF- and has been shown to function as a chemoattractant for monocytes and T lymphocytes (7, 16, 30).”
BackgroundNechama, M., Kwon, J., Wei, S., Tun-Kyi, A., Welner, R. S., Ben‐Dov, I. Z., Arredouani, M. S., Asara, J. M., Chen, C.-H., Tsai, C.-Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03886-6 · Cited by 86
“These four IRAK-M target genes have been shown to be crucial for asthma and other pulmonary disorders 47 – 50 and their roles in granulocytes function have been documented.”
Ye, S., Lowther, S., & Stambas, J. (2014) · Journal of Virology · doi:10.1128/jvi.03529-14 · Cited by 78
“CCL5, also known as RANTES, is induced in response to inflammatory stimuli, such as respiratory syncytial virus (23) and influenza A virus infection (24), acting as a potent chemoattractant for leukocytes at inflammatory sites.”
BackgroundHillyer, P., Shepard, R. E., Uehling, M., Krenz, M., Sheikh, F. G., Thayer, K. R., Huang, L., Yan, L. K., Panda, D., Luongo, C., et al. (2018) · Journal of Virology · doi:10.1128/jvi.02202-17 · Cited by 76
“Similarly, chemokines such as CCL5 recruit leukocytes that participate in local protection against RSV (16), while CXCL8 attracts neutrophils that are associated with high pathogenicity and severe disease that requires hospitalization or assisted ventilation (17).”
BackgroundRole of Platelet Cytokines in Dengue Virus Infection
Singh, A., Bisht, P., Bhattacharya, S., & Guchhait, P. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.561366 · Cited by 74
“CCL5 is reported to be involved in viral lung diseases (Culley et al., 2006).”
BackgroundStegemann‐Koniszewski, S., Jeron, A., Gereke, M., Geffers, R., Kröger, A., Gunzer, M., & Bruder, D. (2016) · mBio · doi:10.1128/mbio.00276-16 · Cited by 63
“Blocking of CCL5 in respiratory viral infection reduces the recruitment of CD4 and CD8 T cells (34), and AECII are the predominant source of CXCL5 in the lungs of mice treated with lipopolysaccharide (35).”
BackgroundRosenberg, H. F., & Domachowske, J. B. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799828346 · Cited by 64
“In a similar experiment performed by Culley and colleagues [79], metRANTES was administered to BALB/c mice that received a primary intranasal inoculum of RSV A2, resulting in diminished expression of CCL5 (RANTES) transcript immediately after inoculation, reduced virus clearance, and diminished recruitment of CD4+ and…”
MethodMelese, E. S., Franks, E., Cederberg, R. A., Harbourne, B., Shi, R., Wadsworth, B. J., Collier, J. L., Halvorsen, E. C., Johnson, F. D., Luu, J., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.2010905 · Cited by 62
“Multiple regulators of CCL5 under different contexts present a clinical challenge to targeting CCL5 production through inhibition of oncogenic signaling.(32)”
BackgroundLung adenocarcinoma invasion in TGFβRII-deficient cells is mediated by CCL5/RANTES
Borczuk, A., Papanikolaou, N. K., Toonkel, R. L., Solé, M., Gorenstein, L. A., Ginsburg, M. E., Sonett, J. R., Friedman, R. A., & Powell, C. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210662 · Cited by 61
“To determine the specificity for signaling through the CCR5 receptor and because the therapeutic potential of Met-RANTES is limited by reports of agonist activity in vivo (Culley et al., 2006), we also tested a CCR5-specific monoclonal-blocking antibody (a-CCR5).”
BackgroundPulmonary Immune Dysregulation and Viral Persistence During HIV Infection
Alexandrova, Y., Costiniuk, C. T., & Jenabian, M.-A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.808722 · Cited by 58
Brand, H. K., Ferwerda, G., Preijers, F. W. M. B., de Groot, R., Neeleman, C., Staal, F. J. T., Warris, A., & Hermans, P. W. M. (2012) · Pediatric Research · doi:10.1038/pr.2012.163 · Cited by 55
Abdul-Careem, M. F., Mian, M. F., Gillgrass, A. E., Chenoweth, M. J., Barra, N. G., Chan, T., Al-Garawi, A. A., Chew, M. V., Yue, G., van Roojen, N., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.09.004 · Cited by 54
Bauer, R. N., Brighton, L. E., Mueller, L., Xiang, Z., Rager, J. E., Fry, R. C., Peden, D. B., & Jaspers, I. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.013 · Cited by 53
Tregoning, J. S., Pribul, P. K., Pennycook, A. M. J., Hussell, T., Wang, B. L., Lukacs, N. W., Schwarze, J., Culley, F. J., & Openshaw, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009381 · Cited by 53
“RSV titer from lungs was assessed using plaque assay as described previously [22].”
MethodInfluentialSelf-citationCastro-Muñoz, L. J., Manzo-Merino, J., Muñoz-Bello, J. O., Olmedo‐Nieva, L., Cedro‐Tanda, A., Alfaro-Ruíz, L. A., Hidalgo‐Miranda, A., Madrid‐Marina, V., & Lizano, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-49886-4 · Cited by 53
Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019
Gracia-Hernandez, M., Sotomayor, E. M., & Villagra, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.577571 · Cited by 54
“CCL5 Met-RANTES Reduce inflammatory cell recruitment and cytokine production (Culley et al., 2006)”
BackgroundRotoli, B. M., Barilli, A., Visigalli, R., Ingoglia, F., Milioli, M., Lascia, M. D., Riccardi, B., Puccini, P., & Dall’Asta, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00508 · Cited by 51
“Activated epithelium is an important source of both CC and CXC chemokines, such as CXCL8/IL8 and CCL5/RANTES: IL8 acts as a key mediator in neutrophil-mediated acute inflammation (35), while RANTES is a potent chemoattractant for blood monocytes, T cells, and eosinophils (36).”
BackgroundBhat, T. A., Kalathil, S. G., Leigh, N. J., Muthumalage, T., Rahman, I., Goniewicz, M. L., & Thanavala, Y. M. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaa267 · Cited by 51
Replication of genetic association studies in asthma and related phenotypes
Undarmaa, S., Mashimo, Y., Hattori, S., Shimojo, N., Fujita, K., Miyatake, A., Doi, S., Kohno, Y., Okamoto, Y., Hirota, T., et al. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.32 · Cited by 48
Surman, S. L., Penkert, R. R., Sealy, R. E., Jones, B. G., Marion, T. N., Vogel, P., & Hurwitz, J. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155570 · Cited by 54
Fetal cytokine response to porcine reproductive and respiratory syndrome virus-2 infection
Pasternak, J. A., MacPhee, D. J., & Harding, J. C. S. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154883 · Cited by 48
Dodd, J. S., Lum, E., Goulding, J., Muir, R., Snick, J. V., & Openshaw, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900085 · Cited by 48
“In animal models, CD8 T cells are the dominant T cell subtype at the time of virus elimination (7), and depletion of T cells or chemokines (such as CCL11 or CCL5) can reduce disease severity (8, 9).”
BackgroundSelf-citationMoratto, D., Giacomelli, M., Chiarini, M., Savarè, L., Saccani, B., Motta, M., Timpano, S., Poli, P., Paghera, S., Imberti, L., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048724 · Cited by 47
“injury and in sustaining CD8 T-cell responses during a viral infection[9].”
BackgroundVitamin D receptor genotype influences risk of upper respiratory infection
Jolliffe, D. A., Greiller, C. L., Mein, C. A., Hoti, M., Bakhsoliani, E., Telcian, A. G., Simpson, A., Barnes, N. C., Curtin, J. A., Čustović, A., et al. (2018) · British Journal Of Nutrition · doi:10.1017/s000711451800209x · Cited by 44
“With regard to specific cytokines and chemokines, IL-1RA plays a key role in resolution of RV infection((35,36)), while CCL5 has been reported to inhibit RSV infection in a human respiratory epithelial cell line((37)) and to promote RSV clearance in mice((38)).”
BackgroundAyala, V. I., Teijaro, J. R., Färber, D. L., Dorsey, S. G., & Carbonetti, N. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019016 · Cited by 41
“Many immune processes are controlled or affected by G proteincoupled chemokine signaling, including pathogen detection, cellular activation, immune cell trafficking, and antigen presentation [80,81,82,83,84].”
BackgroundRespiratory Viruses and Asthma
Ramsahai, J. M., Pathinayake, P. S., Malik, B., Bartlett, N. W., & Wark, P. A. B. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1617412 · Cited by 39
Tavares, L. P., Garcia, C. C., Gonçalves, A. P., Kraemer, L. R., Melo, E. M., Oliveira, F. M. S., de Freitas, C. S., Lopes, G. A. O., dos Reis, D. C., Cassali, G. D., et al. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00134.2019 · Cited by 40
Environmental Cadmium Enhances Lung Injury by Respiratory Syncytial Virus Infection
Hu, X. Y., Kim, K., Lee, Y., Fernandes, J., Smith, M. R., Jung, Y., Orr, M. L., Kang, S., Jones, D. P., & Go, Y. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.04.013 · Cited by 39
“chemokine produced by RSV-infected epithelial cells, activating and recruiting monocyte, eosinophil, and lymphocyte CD4 and CD8 T cells into the airway space.(51,52) It was also reported that RSV-induced chemokine (C-C motif) ligand 5/RANTES contributes to exacerbation of allergic airway inflammation.”
BackgroundCharacterization of immunostimulatory components of orf virus (parapoxvirus ovis)
Friebe, A., Friederichs, S., Scholz, K., Janßen, U., Scholz, C. B., Schlapp, T., Mercer, A. A., Siegling, A., Volk, H., & Weber, O. (2011) · Journal of General Virology · doi:10.1099/vir.0.028894-0 · Cited by 38
“11 On: Tue, 15 Jan 2019 20:09:07 and immune cells (Culley et al., 2006; Kumar et al., 2009), and IL-8RB-1 (CXCR2) mediates cell migration in response to IL-8, a potent chemoattractant (Ben-Baruch et al.”
BackgroundInfluentialCaccuri, F., Bugatti, A., Zani, A., Palma, A. D., Silvestre, D. D., Manocha, E., Filippini, F., Messali, S., Chiodelli, P., Campisi, G., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9071438 · Cited by 38
“From this point of view, HL-mECs act as innate immune cells, able to produce and secrete high levels of pro-inflammatory molecules such as IL-6, but also chemokines recruiting T cells, monocytes, and neutrophils into the inflammatory site, such as IP-10 [71], I-TAC [72], RANTES [73], and growth factors promoting immun…”
BackgroundSu, Y.-C., Townsend, D., Herrero, L. J., Zaid, A., Rolph, M. S., Gahan, M. E., Nelson, M. A., Rudd, P. A., Matthaei, K. I., Foster, P. S., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01536-14 · Cited by 38
“In our study, TARC was associated with vaccine-induced airway inflammation, since its expression was increased in IL-5Tg mice with severe eosinophilic inflammation and reduced in eotaxin- and/or IL-5-deficient mice.”
BackgroundInfluentialRogers, M. C., Lamens, K. D., Shafagati, N., Johnson, M., Oury, T. D., Joyce, S., & Williams, J. V. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800096 · Cited by 34
“CXCL11 Recruit CD4 and CD8 effector T cells to sites of inflammation (44–46) CCL4 (MIP-1b) Made by activated CD8 T cells (47) CX3CL1 Attract and induce endothelial adhesion of activated T cells (48, 49) IL-15 Induce migration of CD8 effector T cells to lung (50) CXCL9 Recruit CD4 and CD8 effector T cells to sites of i…”
BackgroundLocal cytokine response upon respiratory syncytial virus infection
Bueno, S. M., González, P. A., Riedel, C. A., Carreño, L. J., Vasquez, A. E., & Kalergis, A. M. (2011) · Immunology Letters · doi:10.1016/j.imlet.2010.12.003 · Cited by 35
Shabgah, A. G., Jadidi‐Niaragh, F., Mohammadi, H., Ebrahimzadeh, F., Oveisee, M., Jahanara, A., & Navashenaq, J. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.861931 · Cited by 33
Respiratory Syncytial Virus: Pathology, therapeutic drugs and prophylaxis
Gómez, R. S., Guisle, I., Böhmwald, K., Bueno, S. M., & Kalergis, A. M. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.09.006 · Cited by 32
“The most commonly ecreted molecules by epithelial cells in response to hRSV infection re IL-6, IL-8/CXCL8, IL-10, TNF- , RANTES/CCL5, MCP-1/CCL2, IP-1 /CCL3, MIP-1 /CCL4, MIP-2/CXCL2, IP-10/CXCL10 and otaxin-1/CCL11 [63–68].”
BackgroundAlexander, M. R., Brice, A. M., van Vuren, P. J., Rootes, C. L., Tribolet, L., Cowled, C. J., Bean, A. G. D., & Stewart, C. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073392 · Cited by 32
“Moreover, early IL6 and CCL5 signalling enhances recruitment of innate immune cells and resolution lung pathology caused by respiratory syncytial virus [39, 40] suggesting that timing is important for the antiviral activity of these pro-inflammatory cytokines.”
BackgroundKohno, S., Ueji, T., Abe, T., Nakao, R., Hirasaka, K., Oarada, M., Harada‐Sukeno, A., Ohno, A., Higashibata, A., Mukai, R., et al. (2010) · Muscle & Nerve · doi:10.1002/mus.21829 · Cited by 31
Li, D., Wu, P., Liu, H., Feng, T., Yang, W., Ru, Y., Pan, L., Qi, X., Shi, Z., & Zheng, H. (2021) · Journal of Virology · doi:10.1128/jvi.01500-21 · Cited by 30
Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity
Das, D., & Podder, S. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104459 · Cited by 29
“CCL5 is an important pro-inflammatory chemokine that has been shown to be triggered in both primary respiratory syncytial virus (RSV) infection and atherosclerosis [73,74].”
BackgroundEffects of decabrominated diphenyl ether (DBDE) on developmental immunotoxicity in offspring mice
Watanabe, W., Shimizu, T., Hino, A., & Kurokawa, M. (2008) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2008.06.004 · Cited by 29
Hughes, D. J., Kipar, A., Leeming, G. H., Bennett, E., Howarth, D., Cummerson, J. A., Papoula‐Pereira, R., Flanagan, B., Sample, J. T., & Stewart, J. P. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001321 · Cited by 28
“Other studies have shown that blocking RANTES/CCL5 in vivo significantly increases the titers of respiratory syncytial virus in the lungs of infected mice, and this is associated with reduced T cell recruitment [48] and heightened lung disease.”
BackgroundAnderson, J., Do, L. A. H., Toh, Z. Q., Hoe, E., Reitsma, A. J., Mulholland, K., & Licciardi, P. V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00602 · Cited by 27
“Thus, the increase in IL-1β and RANTES levels by VitD3 is important as this enhances clearance of viral infections such as RSV by recruiting T cells and monocytes to the site of infection (39).”
BackgroundContribution of cytokines to pathology and protection in virus infection
Wack, A., Openshaw, P., & O’Garra, A. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.05.015 · Cited by 29
Self-citationChun, Y. H., Park, J. Y., Lee, H., Kim, H. S., Won, S., Joe, H. J., Chung, W. J., Yoon, J., Kim, H. H., Kim, J. T., et al. (2013) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2013.5.4.216 · Cited by 26
“In particular, RANTES is another key proinflammatory chemokine produced by virus-infected epithelial cells and is present in the respiratory secretions of asthmatics.(12) Compared with respiratory disease-free children, greater concentrations of RANTES and MIP-1α have been demonstrated in nasopharyngeal secretions and…”
BackgroundEngineering and screening the N-terminus of chemokines for drug discovery
Chevigné, A., Fiévez, V., Schmit, J., & Deroo, S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.091 · Cited by 25
“[118]”
Song, G. K., Tarrant, T. K., White, T. F., Barrow, D. A., Santos, C., Timoshchenko, R. G., Hanna, S. K., Ramanathan, R. K., Lee, C. R., Bae-Jump, V. L., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.05.007 · Cited by 25
Differential dynamics of peripheral immune responses to acute SARS-CoV-2 infection in older adults
Lewis, S. A., Sureshchandra, S., Zulu, M. Z., Doratt, B. M., Jankeel, A., Ibraim, I. C., Pinski, A. N., Rhoades, N. S., Curtis, M., Jiang, X., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00127-2 · Cited by 23
Rhinovirus Infection and Virus-Induced Asthma
Hayashi, Y., Sada, M., Shirai, T., Okayama, K., Kimura, R., Kondo, M., Okodo, M., Tsugawa, T., Ryo, A., & Kimura, H. (2022) · Viruses · doi:10.3390/v14122616 · Cited by 25
Chang, L. A., Choi, A., Rathnasinghe, R., Warang, P., Noureddine, M., Jangra, S., Chen, Y., Geest, B. G. D., & Schotsaert, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1217181 · Cited by 23
“While studies investigating FI-RSV have identified eosinophil infiltration as a hallmark of VAERD, with a notable contribution from CD4 T cells and Th2 cytokines to the overall phenotype, no mechanistic understanding of how vaccine-induced eosinophil recruitment directly mediates protection from or enhance disease exi…”
BackgroundInfluentialHamed, M. E., Naeem, A., Alkadi, H. S., Alamri, A. A., AlYami, A. S., AlJuryyan, A., Alturaiki, W., Enani, M. A., Al‐Shouli, S. T., Assiri, A. M., et al. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01061-z · Cited by 25
“Previous studies also showed increased levels of RANTES (CCL5) contributed to exacerbation of allergic airway in ammation and severe human respiratory syncytial infection [102]–[104].”
Amanatidou, V., Apostolakis, S. Z., & Spandidos, D. A. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818c8d17 · Cited by 23
Penkert, R. R., Smith, A. P., Hrincius, E. R., McCullers, J. A., Vogel, P., Smith, A. M., & Hurwitz, J. L. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa597 · Cited by 23
Patra, G., Mallik, S., Saha, B., & Mukhopadhyay, S. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.10.017 · Cited by 21
Chiarini, M., Paghera, S., Moratto, D., Rossi, N. D., Giacomelli, M., Badolato, R., Capra, R., & Imberti, L. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577282 · Cited by 21
“The detection of high levels of CCL5, which is involved in IFN-γ -dominant Th1 responses and it is a mediator in T-cell recruitment to the lung, suggests a potential role of this chemokine in the mobilization of T lymphocytes and monocytes to pulmonary tissues (Culley et al., 2006).”
Identification of novel cytokine biomarkers of hexanal exposure associated with pulmonary toxicity
Cho, Y., Song, M., Kim, T. S., & Ryu, J. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.06.041 · Cited by 21
Li, N., Mirzakhani, H., Kiefer, A., Koelle, J., Vuorinen, T., Rauh, M., Yang, Z., Krammer, S., Xepapadaki, P. V., Lewandowska‐Polak, A., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103163 · Cited by 20
Genetic adjuvants: A paradigm shift in vaccine development and immune modulation
Spunde, K., Korotkaja, K., Sominskaya, I., & Zajakina, A. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102536 · Cited by 20
“79 A superagonist of CCR5, known as 1P7, has been engineered through in-vitro evolution using natural CCL5.”
Okabayashi, T., Yokota, S., Yoto, Y., Tsutsumi, H., & Fujii, N. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00033-09 · Cited by 18
“Among the chemokines and proinflammatory cytokines, RANTES and IL-8 are strongly expressed in RSV-infected epithelial cells (25, 27) and are key factors in the pathophysiology of RSV infection (8).”
BackgroundEosinophils as a pharmacological target for the treatment of allergic diseases
Landolina, N., & Levi‐Schaffer, F. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.07.014 · Cited by 17
Inflammatory and oxidative stress biomarkers induced by silica exposure in crystal craftsmen
Carneiro, A. P. S., Algranti, E., Chérot‐Kornobis, N., Bezerra, F. S., Bon, A. M. T., Braz, N. F. T., de Souza, D. M. S., Costa, G. D. P., Bussacos, M. A., Bezerra, O. M. D. P. A., et al. (2020) · American Journal of Industrial Medicine · doi:10.1002/ajim.23088 · Cited by 20
TLR3 activation increases chemokine expression in human fetal airway smooth muscle cells
Faksh, A., Britt, R. D., Vogel, E. R., Thompson, M. A., Pandya, H. C., Martin, R. J., Pabelick, C. M., & Prakash, Y. S. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00151.2015 · Cited by 17
“Chemokines not only mediate cell recruitment to areas of inflammation, but also function to mediate the production of cytokines (13, 62).”
BackgroundYokota, S., Okabayashi, T., Hirakawa, S., Tsutsumi, H., Himi, T., & Fujii, N. (2012) · Mediators of Inflammation · doi:10.1155/2012/528568 · Cited by 16
“Both IL-8 and RANTES, which are strongly upregulated during RSV infection, play important roles in pathogenesis [36, 37].”
BackgroundManipulation of acute inflammatory lung disease
Wissinger, E., Saldaña, J., Didierlaurent, A. M., & Hussell, T. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.16 · Cited by 15
“134 The same strategy has been tested in a mouse model of pneumonia virus infection.”
BackgroundSelf-citationHaist, M., Ries, F., Gunzer, M., Bednarczyk, M., Siegel, E., Kuske, M., Grabbe, S., Radsak, M. P., Bros, M., & Teschner, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.823121 · Cited by 15
Chemokines in Respiratory Viral Infections: Focus on Their Diagnostic and Therapeutic Potential
Amanatidou, V., Zaravinos, A., Apostolakis, S. Z., & Spandidos, D. A. (2011) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v31.i4.40 · Cited by 13
Extracellular Vesicles and Their Role in Lung Infections
Hambo, S., & Harb, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216139 · Cited by 13
“CXCL10 plays an important role as a modulator of the innate and adaptive immune response and as a cell growth regulator and also possesses antagonistic effects [70], while CCL5 recruits CD4 + and CD8 + T cells and has an essential role in controlling viral replication [71].”
BackgroundSherkawi, T. E., Saeid, A. B., Yeung, S., Chellappan, D. K., Mohamad, M. S. B., Kokkinis, S., Sudhakar, S., Singh, S. K., Gupta, G., Paudel, K. R., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155629 · Cited by 14
Type 1 T-cell responses in chlamydial lung infections are associated with local MIP-1α response
Zhang, N., Wang, Z., Tang, X., Wang, H., Li, H., Huang, H., Bai, H., & Yang, X. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.32 · Cited by 13
Li, Q., Wang, Y., Xue, W., Bian, Z., Gao, Y., Zeng, Y., Tang, L., Tang, T., Tian, Y., & Guo, W. Y. (2020) · Pediatric Research · doi:10.1038/s41390-020-0970-y · Cited by 12
Brandys, P., Montagutelli, X., Merenkova, I., Barut, G. T., Thiel, V., Schork, N. J., Trüeb, B. S., Conquet, L., Deng, A., Antanasijevic, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912898 · Cited by 11
“In mouse viral lung disease Ccl5 mRNA in the lung peaks less than a day after primary viral infection with Ccl5 production by resident epithelial cells and lung macrophages during the innate immune response, and then in a second wave at 7 dpi, primarily with Ccl5 production by infiltrating CD4 and CD8 T cells (54).”
BackgroundWindisch, W., Pieper, M., Ziemele, I., Rockstroh, J. K., Brockmann, M. J., Schildgen, O., & Schildgen, V. (2016) · JMM Case Reports · doi:10.1099/jmmcr.0.005052 · Cited by 12
“2), while expressions of RANTES, NAP-2, Eotaxin-2, TIMP-1, TNF-a and TNF-b remain at the same level in the HBoV-negative compared to the HBoV-positive serum.”
BackgroundInfluentialSchiavoni, I., Fedele, G., Quattrini, A., Bianco, M., Schnoeller, C., Openshaw, P., Locht, C., & Ausiello, C. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100166 · Cited by 12
“On the other hand, the MyD88-independent signaling is responsible for the activation of intracellular pathways that, through the activation of IRF3, drive the production of IFNb and, consequently, the expression of IFN-inducible genes such as those coding for CCL5 (also known as RANTES) and the p35 subunit of IL-12p70…”
Self-citationGrandin, C., Lucas‐Hourani, M., Clavel, M., Taborik, F., Vabret, A., Tangy, F., Contamin, H., & Vidalain, P. (2014) · Journal of General Virology · doi:10.1099/vir.0.000039 · Cited by 11
Drysdale, S. B., Thwaites, R. S., Price, J., Thakur, D., McGinley, J., McPherson, C., Öner, D., Aerssens, J., Openshaw, P., & Pollard, A. J. (2024) · Journal of Clinical Virology · doi:10.1016/j.jcv.2024.105731 · Cited by 10
Self-citationNa, W., Lyoo, K., Yoon, S., Yeom, M., Kang, B.-K., Moon, H., Kim, H. K., Jeong, D. G., Kim, J.-K., & Song, D. (2016) · Veterinary Research · doi:10.1186/s13567-016-0400-7 · Cited by 10
“CCL5 is a potent chemotactic cytokine that recruits Th1 and Th2 pro-inflammatory cells and contributes to immunopathology by activating cytotoxic T lymphocytes in the lungs following influenza virus infection [28, 29].”
BackgroundKan‐o, K., Matsumoto, K., Inoue, H., Fukuyama, S., Asai, Y., Watanabe, W., Kurokawa, M., Araya, J., Kuwano, K., & Nakanishi, Y. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000338430 · Cited by 9
Davila, K. M. S., Nelli, R. K., Mora-Díaz, J. C., Sang, Y., Miller, L. C., & Gimenez-Lirola, L. G. (2024) · Viruses · doi:10.3390/v16060939 · Cited by 8
“Finally, this study further demonstrates the potential of the organotypic respiratory culture system as a robust infection model alternative or as a complement to live animals, which can be readily applied across animal species and pathogens.”
BackgroundHaidar, Z., Traboulsi, H., Eidelman, D. H., & Baglole, C. J. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03514-3 · Cited by 8
“CCL5 is produced by CD4+ lymphocytes, epithelial cells, fibroblasts and platelets (Appay and Rowland-Jones 2001) and helps to control virus infection (Culley et al. 2006).”
BackgroundIL-4 Attenuates Pulmonary Epithelial Cell-Mediated Suppression of T Cell Priming
Albrecht, M., Arnhold, M., Lingner, S., Mahapatra, S., Bruder, D., Hansen, G., & Dittrich, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045916 · Cited by 8
Jambo, K., Tembo, D. L., Kamng’ona, A. W., Musicha, P., Banda, D. H., Kankwatira, A., Malamba, R. D., Allain, T. J., Heyderman, R. S., Russell, D. G., et al. (2017) · ERJ Open Research · doi:10.1183/23120541.00097-2017 · Cited by 8
Dong, W., Jin, Y., Shi, H., Zhang, X., Chen, J., Jia, H., & Zhang, Y. (2023) · Medicine · doi:10.1097/md.0000000000033912 · Cited by 7
“[53] During influenza infection in airway and lung cells, IFIT3 can limit the spread of virus, affect the severity of infection and improve cellular defense against virus, IFIT3 may be an important mediator of influenza antiviral response.”
BackgroundSimon, A. Y., Sasaki, N., Ichii, O., Kajino, K., Kon, Y., & Agui, T. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.04.003 · Cited by 7
“Recent studies have demonstrated that inflammatory mediators play essential roles in enhancing respiratory viral pathologies [15-19]; however, several of these mediators have not yet been identified.”
BackgroundThomas, L. H., Friedland, J. S., & Sharland, M. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.3.415 · Cited by 7
Grizer, C. S., Elliott, K. C., Singh, G., Vogt, M. R., & Mattapallil, J. J. (2025) · iScience · doi:10.1016/j.isci.2025.113071 · Cited by 4
Ma, L., Wang, Y., Guo, J., Zhang, X., Xing, S. J., Liu, B., Guo, C., Wang, X., Hu, J., Li, G., et al. (2024) · Toxicology · doi:10.1016/j.tox.2024.154044 · Cited by 4
Linssen, R. S. N., Sridhar, A., Moreni, G., van der Wel, N. N., van Woensel, J. B. M., Wolthers, K. C., & Reinout, A. (2022) · Cells · doi:10.3390/cells11050785 · Cited by 4
Wiwie, C., Rauch, A., Haakonsson, A. K., Barrio‐Hernandez, I., Blagoev, B., Mandrup, S., Röttger, R., & Baumbach, J. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1710.10262 · Cited by 4
Deciphering the Role of Macrophages in RSV Infection and Disease
Looy, S. V., Fransen, A., Jacobs, L., Schaerlaekens, S., Ceconi, M., Serrano‐Cano, F. I., Hudda, N. U., Moll, L. V., Smedt, M. D., Cos, P., et al. (2025) · Viruses · doi:10.3390/v17101351 · Cited by 3
Effects of platelet transfusions on neonatal bleeding and inflammation
Davenport, P. E., Feldman, H. A., Young, V. J., Soule-Albridge, E. L., Kerper, R., Kinlay, S. H., Nolton, E., Stoeckel, A., Denorme, F., Cody, M. J., et al. (2025) · Pediatric Research · doi:10.1038/s41390-025-04498-9 · Cited by 3
Metadata
- Authors
- Culley, F. J., Pennycook, A. M. J., Tregoning, J. S., Dodd, J. S., Walzl, G., Wells, T. N., Hussell, T., & Openshaw, P. J. M.
- Affiliations
- Imperial College London (GB)
- Merck Serono S.A. (Switzerland) (CH)
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-08-15
- Volume
- 80
- Issue
- 16
- Pages
- 8151-8157
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2143412723
- Cited by
- 126
- References
- 40
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 10 · 2021: 11 · 2020: 12 · 2019: 6 · 2018: 8 · 2017: 4 · 2016: 4 · 2015: 2 · 2014: 8 · 2013: 3 · 2012: 9
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Virology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- Wellcome Trust (055303/Z/98/Z, 54797/Z/98/Z, 071381)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- CCL5/RANTES, respiratory syncytial virus, chemokine receptor blockade, eosinophilic inflammation, viral replication, T cell recruitment, CD4 and CD8 T cells
- MeSH terms
- Animals, Eosinophilia, Female, Mice, Inbred BALB C, Pneumonia, Viral, Respiratory Syncytial Viruses, RNA, Messenger, CD4-Positive T-Lymphocytes, Respiratory Syncytial Virus Infections, CD8-Positive T-Lymphocytes, Th2 Cells, Chemokine CCL5, Chemokines, CC, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review